Interginko 120mg Arlico medicine for peripheral circulatory disorders (10 blisters x 10 tablets)

Dosage form Film bag tablets
Specifications Box of 10 blisters x 10 tablets
Ingredient High dry ginkgo leaves

Ingredient

Thành phần cho 1 viên

Composition information	Content
High dry ginkgo leaves	120mg

Uses

indications

Interginko Tablet 120 mg is indicated in the following cases:

Treatment of peripheral circulation disorders (limited limbs). Platelet practice, and shows "the effect of cleaning free radicals". It seems that it also inhibits the production of histamine and leukotrien, which also shows the ability to inhibit the reduction of muscarin -style effects on cholinoCeptor and 2 - adrenoceptor and can change the blood flow properties of blood.

European ginkgo products sold in the form of EGB 761 have shown the stimulating effect on the vestibular multiplication (LVN) and printing - vitro and printing studies - Vivo shows increasing the SYNAP reception of 5 - hydroxytryptamine.

This drug also shows the blockage of ascorbic/Fe2+ acid, causing a decrease in the movement of the Synap body membrane. "The previous occupation of the neuron lipid lipid is caused by ascorbic/Fe2+ acid along with the mobility of the membrane that reduces the ability to transport dopamine to collect dopamine."The Extractum Folium Ginkgo Biloba Siccus) slows down the consumption of O2 (respiratory effort) of stimulated cells by inhibiting NADPH - Oxid, enzymes responsible for O2 decomposition to O2-. As a result, the production of Superoxid (O2) and Hydrogen Peroxyd (H2O2) is significantly reduced when PMNS stimulation is made in the presence of drugs at concentrations of 500, 250 and 125 micrograms/ml. Furthermore. The generation of hydroxyl (OH-) radicals is greatly reduced at low concentrations of 15.6 micrograms of GBE/Mi, which shows that the extract also has the activity of cleaning free radicals. GBE is likely to at least significantly reduce the activity of myeloperoxidase in neutral leukemia.

Dynamic pharmacokinetics

on animals after taking extracts marked with carbon 14, studying the absorption and distribution of the drug shows a quick and complete absorption. The radioactive balance at 72 hours later shows the release in CO2 exhaled and in the urine.

Radioactive peak in the blood is achieved after 1 hour and 30, showing the absorption occurs in the upper stool of the digestive tract.

Research on the distribution of radioactive tissue shows the affinity of the eye and some types of nodes and nerves, especially the hypothalamus, and the pattern.

Ginkgolid A bioavailability is recorded on humans 98 - 100%, Ginkgolid B is 79 - 93% and bilobalid is over 70% or more.

A study of 12 volunteers showed that after taking a single dose high, the ginkgo dose of 0.90 mg to 3.36 mg while the stomach was hungry, the level of bioavailability was highly available. This level is represented by the average values (+/- sd) of the biomedical coefficient (FAUC) with values of 0.8 (+/- 0.09), 0.88 (+/- 0.21) and 0.79 (+/ 0.30) corresponding to Ginkgolid A, Ginkgolid B and Bilobalid.

Food does not replace AUC value but increases Tmax.

LD50 is 7725 mg/kg body weight when used orally in mice, 2 times/day. Therefore toxicity is considered very low.

Before taking Interginko 120mg Arlico medicine for peripheral circulatory disorders (10 blisters x 10 tablets)

How to use

Take oral use.

drink during or after meals.

Dosage

peripheral circulatory disorders, dizziness, tinnitus: 1 tablet/day.

Brain activity disorders: 1 tablet/ time x 1-2 times/ day. The dose can be adjusted depending on the age, or the severity of the symptoms.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What do

do when using overdose?

What to do when forgetting a dose?

If you forget a dose, use it as soon as possible. However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.

Side Effects

When using the 120 mg interginko tablet, you may experience unwanted effects (ADR).

Very rarely causes mild gastrointestinal disorders, in some special cases that can be allergic, circulatory disorders (reducing blood pressure, dizziness, headache, tachycardia), sleeping eyes, skin allergies. Rarely see headache, uncomfortable stomach area, fever, chills and shock.

Instructions on how to handle ADR

When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

Contraindicated

Interginko Tablet 120 mg contraindicated in the following cases:

Patients with hypersensitivity with high ginkgo leaves or any ingredients of the drug.

Children under 12 years old.

Do not replace drugs to treat hypertension, not for myocardial, brain, brain hemorrhage, people with bleeding (coagulation disorders).

Caution when using

Pregnant and lactating women.

The ability to drive and operate machinery

There has been no recognition of the effect of the drug on the ability to drive and operate machinery.

Pregnancy

Safety when used for pregnant women is not known. Interginko tablet 120 mg should not be used for pregnant women.

Breastfeeding period

Should not be used in breastfeeding women because of the ability to interginko tablet 120 mg is excreted through breast milk or not unknown.

Interactive drug

Do not use high and dry ginkgo leaves with drugs to treat painful aspirin, ticlid stroke, Persantin.

Do not use high combination of ginkgo leaves with anticoagulant drugs, anti -plateletic drugs.

Do not use the same anti -epilepsy, depression.

Not used simultaneously with traditional medical drugs with blood only.

Storage

Store in closed packaging, avoid light, avoid moisture, temperature below 300C.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.